Top Markets
Coin of the day
Petros Pharmaceuticals, Inc. Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.

PTPI
Ранг среди акций #40524
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male... Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Цена акции
$0.003
Рыночная капитализация
$127.12K
Изменение (1 день)
0.00%
Изменение (1 год)
-90.00%
Страна
US
Торговля Petros Pharmaceuticals, Inc. (PTPI)

Категория

Коэффициент P/B для Petros Pharmaceuticals, Inc. (PTPI)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Petros Pharmaceuticals, Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Petros Pharmaceuticals, Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов